2648407-76-3
2648407-76-3
Chemical Structure
GT-02216
- CAS No.: 2648407-76-3
- Formula:C22H23N5O2
- Molecular Weight:389.45
InChIKey: XDSBUZIFHCWURQ-UHFFFAOYSA-N
SMILES: O=C(C1=NC(N)=CC(NC2=C(O)C=CC=C2)=C1)N(CC3)CCN3C4=CC=CC=C4
Biological Activity: GT-02216 can bind to GCase allosterically and enhance its activity. GT-02216 enhances the activity of GCase in primary human fibroblasts dose-dependently reduces the accumulation of its substrate, hexosylsphingosine (HexCer). GT-02216 reduces the Tau accumulation in mutant GBA1 fibroblasts. GT-02216 can be used for the study of Parkinson’s disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GT-02216 | 98.91% | GT-02216 can bind to GCase allosterically and enhance its activity. GT-02216 enhances the activity of GCase in primary human fibroblasts dose-dependently reduces the accumulation of its substrate, hexosylsphingosine (HexCer). GT-02216 reduces the Tau accumulation in mutant GBA1 fibroblasts. GT-02216 can be used for the study of Parkinson’s disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
